Salvage TherapyTransplantation, AutologousRecurrenceHodgkin DiseaseCytarabineHematopoietic Stem Cell TransplantationIfosfamideEtoposideAntineoplastic Combined Chemotherapy ProtocolsLymphoma, Non-HodgkinTreatment OutcomeRemission InductionMelphalanCombined Modality TherapySurvival AnalysisDisease-Free SurvivalCyclophosphamideTransplantation ConditioningMultiple MyelomaCarboplatinPrognosisLeukemia, Myeloid, AcuteBone Marrow TransplantationSurvival RateAnemia, RefractoryRefractory Period, ElectrophysiologicalAnemia, Refractory, with Excess of BlastsNeoplasm Recurrence, LocalFollow-Up StudiesPrecursor Cell Lymphoblastic Leukemia-LymphomaDrug Administration ScheduleAntineoplastic AgentsTime FactorsRetrospective StudiesDrug Resistance, NeoplasmTreatment FailureTransplantation, HomologousAntibodies, Monoclonal, Murine-DerivedNeoplasm, ResidualDrug Therapy, CombinationProspective StudiesVincristineImmunosuppressive AgentsInfusions, IntravenousThalidomideAntibodies, MonoclonalDose-Response Relationship, DrugLeukemiaPrednisoneDrug ResistanceGraft vs Host DiseaseMethotrexateAnticonvulsantsAcute DiseaseBoronic AcidsPyrazinesMyelodysplastic SyndromesBehavior, AddictiveVidarabineBone MarrowDrug EvaluationLeukemia, MyeloidEpilepsyLeukemic InfiltrationTesticular NeoplasmsAsparaginaseRefractory Period, PsychologicalDisease ProgressionMitoxantroneImmunologic FactorsIdarubicinArabinonucleosidesMaximum Tolerated DosePrednisoloneNeoplasm StagingDoxorubicinAdministration, OralClinical Trials as TopicRetreatmentLeukemia, LymphoidStem Cell TransplantationMethylprednisoloneHematologic NeoplasmsAnemia, SideroblasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCentral Nervous System NeoplasmsKaplan-Meier EstimateMultiple Sclerosis, Relapsing-RemittingRisk FactorsDexamethasonePain, IntractableWegener GranulomatosisNeoplasmsChronic DiseaseSelf AdministrationCocaine-Related DisordersCarmustineActuarial AnalysisThrombocytopeniaRemission, Spontaneous